Nebenwirkungen · Jascayd
Jascayd 9 mg film-coated tablets Jascayd 18 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 8
HOS-152822 · Präparat HOS-100843
Diarrhoea was the most common adverse reaction associated with treatment discontinuation and occurred most frequently with background nintedanib. Without background IPF treatment, discontinuations occurred in 1% in 18 mg and were not reported in 9 mg or placebo; with background nintedanib, in 13% in 18 mg, 2% in 9 mg and 1% in placebo; with background pirfenidone, no treatment discontinuations were reported in 18 mg or placebo.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-07-21T08:34:55Z · SHA-256 57790d233138c65fd6d481415ca8b09c40ab04d92c89d127ce18d12510d03c97 · Passage 10a889af8120c5aec7a61dea563e2b9c7ac35c2f566afb70b5c8f077b427f026 · Zeichen 4008–4439 im Abschnitt